Aimei Health Technology Stock Current Valuation
| AFJK Stock | 11.00 0.01 0.09% |
Valuation analysis of Aimei Health Technology helps investors to measure Aimei Health's intrinsic value by examining its available valuation indicators, including the cash flow records, the balance sheet account changes and income statement patterns. The value of Enterprise Value Over EBITDA is expected to slide to 424.92. The value of Enterprise Value Multiple is estimated to slide to 424.92. Fundamental drivers impacting Aimei Health's valuation include:
Fairly Valued
Today
Please note that Aimei Health's price fluctuation is very steady at this time. Calculation of the real value of Aimei Health Technology is based on 3 months time horizon. Increasing Aimei Health's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Aimei Health's intrinsic value may or may not be the same as its current market price of 11.00, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 11.0 | Real 10.88 | Hype 11.0 | Naive 11.02 |
The intrinsic value of Aimei Health's stock can be calculated using various methods such as discounted cash flow or dividend analysis. That value may differ from its market price, which is determined by factors such as investor sentiment, market trends, headlines, and other external factors that may influence Aimei Health's stock price.
Estimating the potential upside or downside of Aimei Health Technology helps investors to forecast how Aimei stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Aimei Health more accurately as focusing exclusively on Aimei Health's fundamentals will not take into account other important factors: Aimei Health Technology Company Current Valuation Analysis
Aimei Health's Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Current Aimei Health Current Valuation | 66.74 M |
Most of Aimei Health's fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Aimei Health Technology is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
| Competition |
In accordance with the recently published financial statements, Aimei Health Technology has a Current Valuation of 66.74 M. This is 99.8% lower than that of the Life Sciences Tools & Services sector and significantly higher than that of the Health Care industry. The current valuation for all United States stocks is 99.6% higher than that of the company.
Aimei Current Valuation Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Aimei Health's direct or indirect competition against its Current Valuation to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Aimei Health could also be used in its relative valuation, which is a method of valuing Aimei Health by comparing valuation metrics of similar companies.Aimei Health is currently under evaluation in current valuation category among its peers.
Aimei Health ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Aimei Health's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Aimei Health's managers, analysts, and investors.Environmental | Governance | Social |
Aimei Fundamentals
| Current Valuation | 66.74 M | ||||
| Shares Outstanding | 6.12 M | ||||
| Shares Owned By Insiders | 33.60 % | ||||
| Shares Owned By Institutions | 66.40 % | ||||
| Number Of Shares Shorted | 34 | ||||
| Book Value Per Share | (0.09) X | ||||
| Market Capitalization | 67.32 M |
About Aimei Health Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Aimei Health Technology's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Aimei Health using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Aimei Health Technology based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Aimei Health Piotroski F Score and Aimei Health Altman Z Score analysis. You can also try the Bonds Directory module to find actively traded corporate debentures issued by US companies.
Is Life Sciences Tools & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Aimei Health. If investors know Aimei will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Aimei Health listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Aimei Health Technology is measured differently than its book value, which is the value of Aimei that is recorded on the company's balance sheet. Investors also form their own opinion of Aimei Health's value that differs from its market value or its book value, called intrinsic value, which is Aimei Health's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Aimei Health's market value can be influenced by many factors that don't directly affect Aimei Health's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Aimei Health's value and its price as these two are different measures arrived at by different means. Investors typically determine if Aimei Health is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Aimei Health's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.